We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.
Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Heart Hope

Published 06 May 2011 | By Medpace

Dr Thomas Todaro, Executive Medical Director of Medpace, talks to Future Pharmaceuticals about the global perspectives in Acute Coronary Syndrome (ACS) trial conduct and recruitment.

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details

Help us to better improve our communications by entering all or some of the additional fields below, then click 'Download White Paper' to be taken to the next page.




Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.
I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.
If you would prefer not to hear from carefully selected third party companies uncheck this box



By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory